TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Swedish Orphan Biovitrum AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,647
|
12,441
|
13,317 |
Financial expenses |
5
|
1
|
0 |
Earnings before taxes |
6,250
|
3,589
|
3,992 |
Total assets |
27,326
|
20,798
|
19,014 |
Current assets |
27,316
|
20,767
|
18,955 |
Current liabilities |
5,433
|
2,654
|
2,810 |
Equity capital |
21,893
|
18,143
|
16,204 |
- share capital |
66
|
71
|
75 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
80.1%
|
87.2%
|
85.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.3%
|
28.8%
|
30.0% |
Return on assets (ROA) |
22.9%
|
17.3%
|
21.0% |
Current ratio |
502.8%
|
782.5%
|
674.6% |
Return on equity (ROE) |
28.5%
|
19.8%
|
24.6% |
Change turnover |
8,970
|
-177
|
-603 |
Change turnover % |
77%
|
-1%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.